For research use only. Not for therapeutic Use.
FITC-labeled Tominersen sodium（Cat No.:I041412）is a modified version of Tominersen, an antisense oligonucleotide designed to reduce the production of huntingtin protein in Huntington’s disease. By binding to the mutant huntingtin RNA, Tominersen promotes exon skipping, potentially slowing disease progression. The addition of fluorescein isothiocyanate (FITC) allows for easy visualization and tracking of the oligonucleotide in biological systems using fluorescence microscopy. FITC-labeled Tominersen sodium is commonly used in research to study cellular uptake, distribution, and tissue targeting, aiding in the development and optimization of gene therapies for neurodegenerative disorders like Huntington’s disease.
| Purity | ≥95% |
